Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Boehringer Ingelheim
McKesson
Dow
Colorcon

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

TORSEMIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Torsemide patents expire, and what generic alternatives are available?

Torsemide is a drug marketed by Am Regent, West-ward Pharms Int, Aurobindo Pharma, Corepharma, Hetero Labs Ltd Iii, Hikma Pharms, Par Pharm, Pliva Pharm Ind, Sun Pharm Inds, Teva, and Vintage Pharms. and is included in eleven NDAs.

The generic ingredient in TORSEMIDE is torsemide. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the torsemide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Torsemide

A generic version of TORSEMIDE was approved as torsemide by TEVA on May 14th, 2002.

  Free Forever Trial

Drug patent expirations by year for TORSEMIDE
Drug Prices for TORSEMIDE

See drug prices for TORSEMIDE

Drug Sales Revenue Trends for TORSEMIDE

See drug sales revenues for TORSEMIDE

Recent Clinical Trials for TORSEMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 4
Yale UniversityPhase 3
National Heart, Lung, and Blood Institute (NHLBI)Phase 3

See all TORSEMIDE clinical trials

Pharmacology for TORSEMIDE
Paragraph IV (Patent) Challenges for TORSEMIDE
Tradename Dosage Ingredient NDA Submissiondate
DEMADEX TABLET;ORAL torsemide 020136

US Patents and Regulatory Information for TORSEMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva TORSEMIDE torsemide TABLET;ORAL 076110-001 May 14, 2002 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Sun Pharm Inds TORSEMIDE torsemide TABLET;ORAL 078478-001 Feb 26, 2008 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Teva TORSEMIDE torsemide TABLET;ORAL 076110-002 May 14, 2002 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Sun Pharm Inds TORSEMIDE torsemide TABLET;ORAL 078478-002 Feb 26, 2008 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
McKinsey
Medtronic
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.